Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.33
-0.01-0.75%
Last update: Oct 1, 6:52 PM
$1.33
-0.01-0.75%
NovaBridge Biosciences (NBP) Stock Price, Quote, News & History
NBPNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs,...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of NovaBridge Biosciences (NASDAQ:NBP) through any online brokerage.
Other companies in NovaBridge Biosciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
NovaBridge Biosciences has a consensus price target of $9.00.
The stock price for NovaBridge Biosciences (NASDAQ: NBP) is $1.33 last updated October 1, 2026 at 6:52 PM EDT.
There are no upcoming dividends for NovaBridge Biosciences.
NovaBridge Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for NovaBridge Biosciences.
NovaBridge Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
